blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3199164

EP3199164 - PROCESSES FOR MAKING LACTOSE UTILIZING PRE-CLASSIFICATION TECHNIQUES AND PHARMACEUTICAL FORMULATIONS FORMED THEREFROM [Right-click to bookmark this link]
StatusOpposition rejected
Status updated on  27.05.2022
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  14.02.2020
FormerGrant of patent is intended
Status updated on  15.10.2019
FormerExamination is in progress
Status updated on  06.04.2018
FormerRequest for examination was made
Status updated on  04.07.2017
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR
published on 17.07.2024  [2024/29]
Applicant(s)For all designated states
Glaxo Group Limited
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
For all designated states
DMV-Fonterra Excipients Technology GmbH
Klever Strasse 187
47574 Goch / DE
[2017/31]
Inventor(s)01 / NEWMAN, Stephen
c/o GlaxoSmithKline
Park Road
Ware, Hertfordshire SG12 0DP / GB
02 / DAMHUIS, Rudolf Johanus
c/o Friesland Foods Domo
Needsweg 23
7271 AB Borculo / NL
 [2017/31]
Representative(s)EIP
Fairfax House
15 Fulwood Place
London WC1V 6HU / GB
[N/P]
Former [2017/31]Shore, Andrew David
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date16191843.806.02.2006
[2017/31]
Priority number, dateUS20050651755P10.02.2005         Original published format: US 651755 P
[2017/31]
Previously filed application, dateWO2006US0403206.02.2006
[2017/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3199164
Date:02.08.2017
Language:EN
[2017/31]
Type: B1 Patent specification 
No.:EP3199164
Date:18.03.2020
Language:EN
[2020/12]
Search report(s)(Supplementary) European search report - dispatched on:EP12.06.2017
ClassificationIPC:A61K31/7016, A61K31/715, C07H3/00, C13K5/00, A61K9/00
[2017/31]
CPC:
C13K5/00 (EP,US); A61K9/20 (KR); A61K31/7016 (EP,US);
A61K31/715 (EP,US); A61K47/36 (KR); A61K9/0075 (EP,US);
A61P11/00 (EP); C07H3/00 (EP,US); A61K9/145 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/31]
Extension statesHR30.09.2016
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON LACTOSE UNTER VERWENDUNG VON VORKLASSIFIZIERUNGSVERFAHREN SOWIE DAMIT ERZEUGTE PHARMAZEUTISCHE FORMULIERUNGEN[2017/31]
English:PROCESSES FOR MAKING LACTOSE UTILIZING PRE-CLASSIFICATION TECHNIQUES AND PHARMACEUTICAL FORMULATIONS FORMED THEREFROM[2017/31]
French:PROCEDES DE FABRICATION DU LACTOSE AU MOYEN DE TECHNIQUES DE PRE-CLASSIFICATION ET PREPARATIONS PHARMACEUTIQUES AINSI OBTENUES[2017/31]
Examination procedure30.09.2016Examination requested  [2017/31]
30.09.2016Date on which the examining division has become responsible
22.01.2018Amendment by applicant (claims and/or description)
09.04.2018Despatch of a communication from the examining division (Time limit: M06)
05.10.2018Reply to a communication from the examining division
16.10.2019Communication of intention to grant the patent
30.01.2020Fee for grant paid
30.01.2020Fee for publishing/printing paid
30.01.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP06734392.1  / EP1848444
Opposition(s)Opponent(s)01  18.12.2020  14.01.2021  ADMISSIBLE
Adamson Jones
BioCity Nottingham
Pennyfoot Street
Nottingham NG1 1GF / GB
Opponent's representative
Adamson Jones
Park View House
58 The Ropewalk
Nottingham NG1 5DW / GB
 [N/P]
Former [2021/17]
Opponent(s)01  18.12.2020  14.01.2021  ADMISSIBLE
Adamson Jones
BioCity Nottingham
Pennyfoot Street
Nottingham NG1 1GF / GB
Opponent's representative
Adamson Jones
BioCity Nottingham
Pennyfoot Street
Nottingham NG1 1GF / GB
Former [2021/04]
Opponent(s)01  18.12.2020   
Adamson Jones
BioCity Nottingham
Pennyfoot Street
Nottingham NG1 1GF / GB
Opponent's representative
Adamson Jones
BioCity Nottingham
Pennyfoot Street
Nottingham NG1 1GF / GB
21.01.2021Invitation to proprietor to file observations on the notice of opposition
19.05.2021Reply of patent proprietor to notice(s) of opposition
12.01.2022Cancellation of oral proceeding that was planned for 09.03.2022
10.02.2022Date of despatch of rejection of opposition
20.02.2022Legal effect of rejection of opposition [2022/26]
09.03.2022Date of oral proceedings
Fees paidRenewal fee
30.09.2016Renewal fee patent year 03
30.09.2016Renewal fee patent year 04
30.09.2016Renewal fee patent year 05
30.09.2016Renewal fee patent year 06
30.09.2016Renewal fee patent year 07
30.09.2016Renewal fee patent year 08
30.09.2016Renewal fee patent year 09
30.09.2016Renewal fee patent year 10
30.09.2016Renewal fee patent year 11
07.02.2017Renewal fee patent year 12
07.02.2018Renewal fee patent year 13
08.02.2019Renewal fee patent year 14
10.02.2020Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.02.2006
AT18.03.2020
CY18.03.2020
CZ18.03.2020
DK18.03.2020
EE18.03.2020
ES18.03.2020
FI18.03.2020
IT18.03.2020
LT18.03.2020
LV18.03.2020
MC18.03.2020
NL18.03.2020
PL18.03.2020
RO18.03.2020
SE18.03.2020
SI18.03.2020
SK18.03.2020
TR18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
IE06.02.2021
LU06.02.2021
BE28.02.2021
CH28.02.2021
LI28.02.2021
[2024/29]
Former [2023/27]HU06.02.2006
AT18.03.2020
CY18.03.2020
CZ18.03.2020
DK18.03.2020
EE18.03.2020
ES18.03.2020
FI18.03.2020
IT18.03.2020
LT18.03.2020
LV18.03.2020
MC18.03.2020
NL18.03.2020
PL18.03.2020
RO18.03.2020
SE18.03.2020
SI18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
IE06.02.2021
LU06.02.2021
BE28.02.2021
CH28.02.2021
LI28.02.2021
Former [2023/24]AT18.03.2020
CY18.03.2020
CZ18.03.2020
DK18.03.2020
EE18.03.2020
ES18.03.2020
FI18.03.2020
IT18.03.2020
LT18.03.2020
LV18.03.2020
MC18.03.2020
NL18.03.2020
PL18.03.2020
RO18.03.2020
SE18.03.2020
SI18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
IE06.02.2021
LU06.02.2021
BE28.02.2021
CH28.02.2021
LI28.02.2021
Former [2022/33]AT18.03.2020
CZ18.03.2020
DK18.03.2020
EE18.03.2020
ES18.03.2020
FI18.03.2020
IT18.03.2020
LT18.03.2020
LV18.03.2020
MC18.03.2020
NL18.03.2020
PL18.03.2020
RO18.03.2020
SE18.03.2020
SI18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
IE06.02.2021
LU06.02.2021
BE28.02.2021
CH28.02.2021
LI28.02.2021
Former [2022/07]AT18.03.2020
CZ18.03.2020
DK18.03.2020
EE18.03.2020
ES18.03.2020
FI18.03.2020
IT18.03.2020
LT18.03.2020
LV18.03.2020
MC18.03.2020
NL18.03.2020
PL18.03.2020
RO18.03.2020
SE18.03.2020
SI18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
IE06.02.2021
LU06.02.2021
CH28.02.2021
LI28.02.2021
Former [2021/47]AT18.03.2020
CZ18.03.2020
DK18.03.2020
EE18.03.2020
ES18.03.2020
FI18.03.2020
IT18.03.2020
LT18.03.2020
LV18.03.2020
MC18.03.2020
NL18.03.2020
PL18.03.2020
RO18.03.2020
SE18.03.2020
SI18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
LU06.02.2021
CH28.02.2021
LI28.02.2021
Former [2021/41]AT18.03.2020
CZ18.03.2020
DK18.03.2020
EE18.03.2020
ES18.03.2020
FI18.03.2020
IT18.03.2020
LT18.03.2020
LV18.03.2020
MC18.03.2020
NL18.03.2020
PL18.03.2020
RO18.03.2020
SE18.03.2020
SI18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
Former [2021/24]AT18.03.2020
CZ18.03.2020
DK18.03.2020
EE18.03.2020
ES18.03.2020
FI18.03.2020
IT18.03.2020
LT18.03.2020
LV18.03.2020
NL18.03.2020
PL18.03.2020
RO18.03.2020
SE18.03.2020
SI18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
Former [2021/10]AT18.03.2020
CZ18.03.2020
DK18.03.2020
EE18.03.2020
ES18.03.2020
FI18.03.2020
IT18.03.2020
LT18.03.2020
LV18.03.2020
NL18.03.2020
PL18.03.2020
RO18.03.2020
SE18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
Former [2021/09]AT18.03.2020
CZ18.03.2020
DK18.03.2020
EE18.03.2020
ES18.03.2020
FI18.03.2020
IT18.03.2020
LT18.03.2020
LV18.03.2020
NL18.03.2020
RO18.03.2020
SE18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
Former [2021/08]CZ18.03.2020
DK18.03.2020
EE18.03.2020
ES18.03.2020
FI18.03.2020
LT18.03.2020
LV18.03.2020
NL18.03.2020
RO18.03.2020
SE18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
Former [2020/50]CZ18.03.2020
EE18.03.2020
FI18.03.2020
LT18.03.2020
LV18.03.2020
NL18.03.2020
RO18.03.2020
SE18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
Former [2020/49]CZ18.03.2020
FI18.03.2020
LT18.03.2020
LV18.03.2020
NL18.03.2020
RO18.03.2020
SE18.03.2020
SK18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
PT12.08.2020
Former [2020/47]FI18.03.2020
LT18.03.2020
LV18.03.2020
NL18.03.2020
SE18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
Former [2020/46]FI18.03.2020
LV18.03.2020
NL18.03.2020
SE18.03.2020
BG18.06.2020
GR19.06.2020
IS18.07.2020
Former [2020/45]FI18.03.2020
LV18.03.2020
NL18.03.2020
SE18.03.2020
BG18.06.2020
GR19.06.2020
Former [2020/39]FI18.03.2020
LV18.03.2020
SE18.03.2020
BG18.06.2020
GR19.06.2020
Former [2020/38]FI18.03.2020
LV18.03.2020
SE18.03.2020
GR19.06.2020
Former [2020/35]FI18.03.2020
Documents cited:Search[X]WO9623485  (CO ORDINATED DRUG DEV [GB], et al) [X] 1-15* examples 3, 45 *;
 [A]WO03088943  (GLAXO GROUP LTD [GB], et al) [A] 1-15 * claim 10 *
ExaminationWO9511666
 WO0033811
 WO2004017914
by applicantGB2064336
 EP0069715
 GB2129691
 GB2169265
 GB2178965
 US4778054
 US4811731
 US5035237
 GB2242134
 US5590645
 US5860419
 US5873360
 US6032666
 US6143277
 US6170717
 US6253762
 US6315173
 US6318603
 US6321747
 US6360739
 US6378519
 US6390291
 US6431168
 US6511653
 US6532955
 US6536427
 US6546928
    - X. M. ZENG ET AL., INTERNATIONAL JOURNAL OF PHARMACEUTICS, (1998), vol. 176, pages 99 - 110
 US20050651754
OppositionUS3634582
 WO9511666
 US5478578
 WO9623485
 WO0033811
 WO03088943
 WO2004017914
    - Damhuis Rudie, Diepenmaat Paul, Te Wierik Henk, "Formulation of Lactose for Inhaled Delivery Systems", Pharmaceutical Technology Europe, (20021101), vol. 14, no. 11, XP093002131
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.